A recent study showed that high expression of PD-L1 on immune cells was associated with decreased survival, while high expression of PD-L1 on tumor cells was associated with increased survival (Chen et al., 2020), indicating another level of complexity of how these molecules effect outcomes. The gene discussed is CD274; the disease is neoplasm.